NanoEntek launches fully automated cell counter for high-throughput labs

NanoEntek has launched the EVE™ HT A26, a walk-away cell counter that can process up to 96 samples in 10 minutes with minimal hands-on time. The system is aimed at labs that need faster, more consistent counting across large batches and regulated workflows.

Why it matters: - High-throughput labs need faster sample processing without adding user-to-user variability. - The EVE HT A26 is built to automate the steps that often create inconsistent results in manual cell counting. - The system targets workflows where speed, reproducibility and data integrity matter, including cell culture, cell-based assays, bioprocessing and cell therapy development.

What happened: - NanoEntek Inc. announced the launch of the EVE™ HT A26, a fully automated high-throughput cell counter. - The instrument is available now. - The product is for research use only and is not approved for diagnostic or therapeutic use. - NanoEntek said the system is designed to streamline the workflow from sample preparation to counting and analysis.

The details: - The EVE HT A26 can count up to 96 samples in as little as 10 minutes. - The system requires only 20 µL of sample. - Once users load consumables and samples, the instrument performs aliquoting, diluting, mixing, loading and counting. - The platform combines dual fluorescence and brightfield channels. - Supported stains include AO/DAPI, Trypan Blue and Erythrosin B. - Built-in auto-aliquoting and dilution standardize sample preparation. - NanoEntek says the automated workflow reduces variability and supports reproducible results across users and runs. - An optional 21 CFR Part 11-compliant configuration supports data-integrity requirements in regulated environments. - The company said the system also delivers the imaging performance of a fluorescence cell counter.

Between the lines: - The launch positions NanoEntek against a common pain point in labs: manual prep steps that slow workflows and introduce inconsistency. - The emphasis on walk-away operation suggests the company is selling labor savings as well as throughput. - The 21 CFR Part 11 option signals an effort to reach regulated buyers, not just academic research labs. - NanoEntek framed reproducibility as the key benefit, which may matter more than raw speed for many users.

What's next: - NanoEntek is likely to market the EVE HT A26 to laboratories running repeated large-batch workflows. - The company is also likely to lean on regulated-environment features to broaden adoption beyond basic research settings. - NanoEntek said the instrument is intended to help scientists spend less time at the bench while maintaining consistent results.

The bottom line: - The EVE HT A26 is a fully automated cell-counting platform built to cut hands-on time and standardize results across high-volume lab workflows. - NanoEntek is betting that consistency, not just speed, will drive adoption.